UCB (EBR:UCB) UCB Media Room - Transparency notification FMR LLC.

Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires

09/08/2021 20:07
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg ** Transparency notification FMR LLC. ------------------------------------------------------------ =C2=B7 Notification referring to situation on 30 July 2021 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 3.63 % Brussels (Belgium), 9 August 2021 =E2=80=93 20:00 (CEST) =E2=80=93 regulate= d information 1. Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB=C2=A0SA/NV announces that it has received a transparency= notification from FMR LLC. (having its registered office at The Corporatio= n Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware= 19801, U.S.A.), on 5 August 2021. FMR LLC., has notified that, following an acquisition of UCB=C2=A0shares wi= th voting rights by its affiliates, its holding in UCB shares with voting r= ights has increased and has crossed for the first time the 5% threshold on = 30 July 2021. On 30 July 2021, FMR LLC. (taking into account the holding of its affiliate= s) owned 9 728 407 UCB=C2=A0shares with voting rights, representing 5.00% o= f the total number of shares issued by the company (194 505 658). 1. Content of the notification =C2=B7 Reason for the notification: Acquisition or disposal of voting secur= ities or voting rights. =C2=B7 Notification by: A parent undertaking or a controlling person. =C2=B7 Persons subject to the notification requirement: https://mb.cision.com/Public/18595/3393930/b1a7ac467d5e03d6_800x800ar.png =C2=B7 Date on which the threshold is crossed: 30 July 2021. =C2=B7 Threshold crossed (in %): 5%. =C2=B7 Denominator: 194 505 658. =C2=B7 Notified details: https://mb.cision.com/Public/18595/3393930/8b907e1523e8758b_800x800ar.png =C2=B7 Chain of controlled undertakings through which the holding is effect= ively held: https://mb.cision.com/Public/18595/3393930/ac2a4643187976cf_800x800ar.png =C2=A0 1. Further information This press release and the detailed transparency notification are available= on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://www.uc= b.com/investors/UCB-shareholders/Transparency-notifications) . An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail= able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://ww= w.ucb.com/investors/UCB-shareholders) . =C2=A0 Investor Relations Antje Witte Investor Relations, UCB T +32 2 559 94 14 antje.witte@ucb.com =C2=A0 Corporate Communications Laurent Schots Media Relations, UCB T+32.2.559.92.64 laurent.schots@ucb.com =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com (http://www.ucb.com) ) is a global biop= harmaceutical company focused on the discovery and development of innovativ= e medicines and solutions to transform the lives of people living with seve= re diseases of the immune system or of the central nervous system. With app= roximately 8 400 people in nearly 40 countries, the company generated reven= ue of =E2=82=AC 5.3 billion in 2020. UCB is listed on Euronext Brussels (sy= mbol: UCB). Follow us on Twitter: @UCB_news GenericFile 210809 - Transparency notification press release FMR LLC (https://mb.cision= .com/Public/18595/3393930/aba1c576d6af70be.pdf) GenericFile 210809 - Notification de transparence comm de presse FMR LLC (https://mb.ci= sion.com/Public/18595/3393930/aeea62953b5b0764.pdf) GenericFile 210809 - Transparantieverklaring persbericht FMR LLC (https://mb.cision.com= /Public/18595/3393930/9ff84339b1796b5b.pdf)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x79015x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=